EUVIMEDEUVIMED entdecken
Open Access

Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B

Ying Xie iD, Sophie Irwin iD, Andrea Chupina Estrada iD, Becca Nelson iD, Ashlen Bullock iD, Lindsey Fontenot iD, Hanping Feng iD, Mingjun Sun iD, Hon Wai Koon iD

The Journal of Infectious Diseases · 23.09.2024 · 230 (3) · 545-557

DOI: 10.1093/infdis/jiae021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 19.01.2024. Verfasst von Ying Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles,…. Hauptthemen laut MEDLINE: Clostridioides difficile, Anti-Inflammatory Agents, Loratadine, Leukocytes, Mononuclear. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CCF, China Scholarship Council, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clostridium difficile infection (CDI) is a debilitating nosocomial infection. C. difficile produces toxins A and B, which cause inflammation. Existing therapies have issues with recurrence, cost, and safety. We aim to discover a safe, effective, and economical nonmicrobiological therapeutic approach against CDI.

Methods

We included human primary peripheral blood mononuclear cells (PBMCs), fresh human colonic explants, and humanized HuCD34-NCG mice. Toxin A+B+ VPI 10463 and A−B+ ribotype 017 C. difficile strains were used. We used single-cell RNA profiling and high-throughput screening to find actionable toxin B–dependent pathways in PBMCs.

Results

Histamine 1 receptor–related drugs were found among the hit compounds that reversed toxin-mediated macrophage inflammatory protein (MIP) 1α expression in PBMCs. We identified loratadine as the safest representative antihistamine for therapeutic development. Loratadine inhibited toxin B–induced MIP-1α secretion in fresh human colonic tissues. Oral loratadine (10 mg/kg/d) maintained survival, inhibited intestinal CCl3 messenger RNA expression, and prevented vancomycin-associated recurrence in the VPI 10463–infected mice and ribotype 017-infected hamsters. Splenocytes from loratadine-treated mice conferred anti-inflammatory effects to the VPI 10463–infected T/B-cell­–deficient Rag−/− mice. Oral loratadine suppressed human MIP-1α expression in monocytes/macrophages in toxin B–expressing ribotype 017-infected humanized HuCD34-NCG mice.

Conclusions

Loratadine may be repurposed to optimize existing therapies against CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileAnti-Inflammatory AgentsLoratadineLeukocytes, MononuclearBacterial ToxinsBacterial ProteinsAnimalsHumansMiceClostridium InfectionsColonEnterotoxinsChemokine CCL3

Stichwörter der Autor:innen

cytokinehistamine receptorsplenocytes

Substanzen

toxB protein, Clostridium difficileAnti-Inflammatory AgentsLoratadineBacterial ToxinsBacterial ProteinsEnterotoxinsChemokine CCL3

Autor:innen und Institutionen

  • Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Gastroenterology, The First Hospital of China Medical University, Shenyang City, China.
  • Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, Maryland, USA.

ORCID-Profile: Ying Xie, Sophie Irwin, Andrea Chupina Estrada, Becca Nelson, Ashlen Bullock, Lindsey Fontenot, Hanping Feng, Mingjun Sun, Hon Wai Koon

Förderung

  • CCF
  • China Scholarship Council
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Crohn’s & Colitis Foundation

Zitieren

APA

Xie, Y., Irwin, S., Chupina Estrada, A., Nelson, B., Bullock, A., Fontenot, L., Feng, H., Sun, M., & Koon, H. W. (2024). Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B. The Journal of Infectious Diseases, 230(3), 545-557. https://doi.org/10.1093/infdis/jiae021

Vancouver

Xie Y, Irwin S, Chupina Estrada A, Nelson B, Bullock A, Fontenot L, et al. Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B. The Journal of Infectious Diseases. 2024;230(3):545-557. doi:10.1093/infdis/jiae021

BibTeX
@article{Xie2024,
  author = {Xie, Ying and Irwin, Sophie and Chupina Estrada, Andrea and Nelson, Becca and Bullock, Ashlen and Fontenot, Lindsey and Feng, Hanping and Sun, Mingjun and Koon, Hon Wai},
  title = {Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {3},
  pages = {545--557},
  doi = {10.1093/infdis/jiae021}
}
Kostenlos starten →